70: HealthTech Hour with Steve Roest - Episode 7070: HealthTech Hour with Steve Roest - Episode 70
UK Health Radio Podcast
Steve Roest and Dr. Mark Hudson-Peacock explore pharmacogenomics, discussing its potential to personalise medicine and improve treatment outcomes.
54:00•16 Dec 2025
Revolutionising Healthcare: Pharmacogenomics with Dr. Mark Hudson-Peacock
Episode Overview
- Pharmacogenomics tailors medication based on genetic profiles.
- Current medications often work for only 30-50% of patients.
- Pilot projects in England aim to integrate pharmacogenomics into stroke care.
- The pharmaceutical industry may revive drugs using genetic insights.
- Education is crucial for adopting pharmacogenomics in healthcare.
“"You're tossing a coin every time you give a medication to a patient as to whether it will work or not."”
How do individuals turn their lives around after addiction? This week's HealthTech Hour with Steve Roest offers a fascinating look into the cutting-edge world of pharmacogenomics and its potential to revolutionise healthcare. Dr. Mark Hudson-Peacock, founder and CEO of Mantara, joins the conversation to discuss how genetic testing can tailor medication to individual needs, potentially reducing side effects and increasing efficacy.
With pharmacogenomics being a hot topic in healthcare innovation, this episode sheds light on its current status and future prospects. Dr. Hudson-Peacock explains how pharmacogenomic testing can personalise treatments, particularly for mental health and cardiovascular conditions, offering hope for more effective healthcare solutions. The discussion isn't just about the science; it's also about the practicalities of implementing such technology within existing healthcare systems.
From the challenges of gaining acceptance among medical professionals to the logistical hurdles of widespread adoption, you'll gain a comprehensive understanding of where we stand today. The episode also touches on the broader implications for the pharmaceutical industry, suggesting a future where drugs are designed with genetic profiles in mind. For those interested in the intersection of technology and healthcare, this episode provides a window into the transformative potential of pharmacogenomics.
It's an engaging listen that combines expert insights with real-world applications, making complex topics accessible and intriguing. Are we on the brink of a healthcare revolution? Tune in to find out.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.